期刊文献+

418例药物性肝损害临床特征及预后分析 被引量:64

The clinical features and prognosis analysis of 418 patients with drug-induced liver injury
下载PDF
导出
摘要 目的分析引起药物性肝损害的药物种类,探讨其临床特征及预后。方法回顾性总结我院近3年收治的418例药物性肝损害患者临床资料,分析其药物种类、临床表现、肝脏生化学检测、肝穿刺病理及治疗转归等相关指标。结果引起药物性肝损害前5类药物分别是中药、抗生素、解热镇痛药、抗结核药、心血管药。418例患者中急性药物性肝损害218例(占52.2%);慢性药物性肝损害112例(占26.8%);药物性肝功能衰竭81例(占19.4%);药物性肝硬化7例(占1.7%)。418例药物性肝损害患者中治愈152例(36.4%),好转206例(49.3%),无效47例(11.2%),死亡13例(3.1%)。影响预后的肝功能指标为AST、TBil、Alb、CHE、PTA。结论药物性肝损害的的致病药物种类较多,临床表现缺乏特异性,AST、TBil、Alb、CHE、PTA与预后具有明显的相关性。 Objective To investigate the etiology, clinical feature and related prognosis factors of patients with drug-induced liver injury(DILI). Methods Four hundred and eighteen patients with DILI admitted to our hospital from February 2009 to February 2012 were retrospectively reviewed according to their drug history, clinical features, lab tests, complications and related prognosis factors. Results The etiological drugs of DILI primarily were herbal medicine, antibiotics, antipyretic analgesic, anti-tuberculosis and cardiovascular drugs. Among the 418 patients with DILl, 52.2% were acute DILl, 26. 8% were chronic DILI, 19. 4% were drug-induced liver failure, and 1. 7% were drug-induced cirrhosis, respectively. The overall cure rate was 36.4%, the improvement rate was 49.3%, the worsening rate was 11.2%, and the mortality rate was 3. 1%. The prognosis factors of DILI were levels of AST, TBil, Alb, CHE and PTA. Conclusion Various kinds of drugs could cause liver injury. Patients with DILI had specific clinical manifestation. The prognosis factors of DILl are correlated with levels of AST, TBil, Alb, CHE and PTA.
出处 《肝脏》 2013年第1期11-14,共4页 Chinese Hepatology
关键词 药物性肝损害 临床特征 病理 预后 Drug-induced liver injury Clinical features Prognosis
  • 相关文献

参考文献16

  • 1Ikeda T. Drug-induced liver injury[J].Nippon Yakurigaku Zasshi Folia Pharmacologica Japonica,2006.454-459.
  • 2Christina WN,Christoph S. Drug induced liver injury and its relationship to autoimmune hepatitis[J].Journal of Hepatology,2011.747-749.
  • 3Maria VA,Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis[J].Hepatology,1997.664-669.
  • 4中华医学会感染病学分会肝功能衰竭与人工肝学组;中华医学会肝病学分会重型肝病与人工肝学组.肝功能衰竭诊疗指南[J]中华肝脏病杂志,2006643-646.
  • 5Benichou C. Criteria of drug-induced liver disorders:report of an international consensus meeting[J].Journal of Hepatology,1990.272-276.
  • 6Aithal GP,Watkins PB,Andrade RJ. Case definition and phenotype standardization in drug-induced liver injury[J].Clinical Pharmacology and Therapeutics,2011.806-815.
  • 7Au JS,Navarro VJ,Rossi S. Review article:drug induced liver injury-its pathophysiology and evolving diagnostic tools[J].Alimentary Pharmacology and Therapeutics,2011.11-20.
  • 8Karen F,Murray,Nedim Hadzic. Drug related hepatotoxicity and acute liver failure[J].Journal of Pediatric Gastroenterology and Nutrition,2008.395-405.
  • 9Verma S,Kaplowitz N. Diagnosis,management and prevention of drug-induced liver injury[J].Gut,2009.1555-1564.
  • 10魏傲,石小枫.药物性肝炎344例临床分析[J].现代医药卫生,2010,26(23):3528-3530. 被引量:6

二级参考文献22

  • 1刘平.加强抗肝纤维化作用机制的研究[J].中华肝脏病杂志,2005,13(8):561-562. 被引量:14
  • 2张涛,贾继东.87例药物性肝损害病因和临床表现分析[J].中国临床医生杂志,2006,34(3):29-31. 被引量:9
  • 3Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:828
  • 4Hoofnagle JH. Drug-induced liver injury network(DILIN)[J].Hepatology, 2004,40 : 773.
  • 5Teleman MD, Chee CBE, Earnest A, et al.Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore[J]. Int Tuberc Lung Dis, 2002,6(8) : 699.
  • 6Aithal GP, Watkins PB, Andrade R J, et al. Case definition and phe- notype standardization in drug-induced liver injury[J ]. Clin Phar- macol Ther, 2011, 89(6):806-815.
  • 7Au JS, Navarro VJ, Rossi S. Drug-induced liver injury-- its pathe- physiology and evolving diagnostic tools[J]. Aliment Pharmacol Ther, 2011,34(1): 11-20.
  • 8Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis[Jl. Hepatology, 1997, 26(3):664-669.
  • 9Ikeda T. Drug-induced liver injury[J]. Nippon Yakurigaku Zasshi, 2006, 127(2): 454-459.
  • 10Bawany MZ, Bhutto B, Youssef WI, et al. Acute liver failure: an uncommon complication of commonly used medication [EB/OL].[2011-07-01]. http://www.biomedsearch.com/nih/Acute-Liver-Fai- lure-Uncommon-Complication/21642826.html.

共引文献31

同被引文献674

引证文献64

二级引证文献356

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部